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Risk of bacteremia from temporary hemodialysis catheters by available. The National Kidney Foundation-Dialysis Out-
site of insertion and duration of use: A prospective study. comes Quality Initiative (NKF-DOQI) guidelines recom-
Background. Uncuffed, nontunneled hemodialysis cathe- mend that temporary catheters should remain in place noters remain the preferred means to gain immediate access to
longer than 5 days at the femoral vein and 21 days in thethe circulation for hemodialysis. Bacteremia is the primary
internal jugular site and subclavian site based on the cumu-complication that limits their use. The risk of bacteremia by
site of insertion and duration of use has not been well studied. lative risk of bacteremia [1]. The committee acknowledged
Methods. Two hundred eighteen consecutive patients who that this recommendation was primarily opinion-based
required a temporary hemodialysis catheter were prospectively
and that large prospective studies of bacteremia fromfollowed.
temporary catheters had not been performed. This studyResults. Catheters were placed at 318 new insertion sites
and remained in use for a total of 6235 days. The incidence of was undertaken to better characterize the risk of bacter-
bacteremia was 5.4% after three weeks of placement in internal emia according to duration of use and site of insertion,
jugular vein and 10.7% after one week in femoral vein [relative particularly at the femoral and internal jugular sites.risk for bacteremia 3.1 (95% CI, 1.8 to 5.2)]. The incidence of
bacteremia was 1.9% one day after the onset of an exit site
infection but increased to 13.4% by the second day if the METHODScatheter was not removed. Guidewire exchange for malfunc-
tion and patient factors did not significantly affect the risk of Patients were prospectively followed at St. Joseph’s
bacteremia. Hospital (Hamilton, Ontario, Canada), which serves ap-
Conclusions. Internal jugular catheters may be left in place proximately 600 patients with end-stage renal diseasefor up to three weeks without a high risk of bacteremia, but
and is a referral center for acute renal failure. All patientsfemoral catheters in bed-bound patients should be removed
who received a temporary hemodialysis catheter (Arrowafter one week. Catheter exchanges over a guidewire for catheter
malfunction do not increase bacteremia rates. Temporary cathe- International, Reading, PA, USA) from December 1996
ters should be removed immediately if an exit site infection occurs. to December 1997 were followed from the day of cathe-
ter insertion to the day the catheter was no longer needed.
Any given patient could receive multiple catheters at
Uncuffed, nontunneled hemodialysis catheters are an multiple insertion sites in order to maintain access. Base-
essential method of gaining immediate access to the cir- line patient data were recorded at the time of insertion.
culation, but bacteremia complicates their use. Tempo- Catheters were inserted by attending nephrologists
rary catheters are usually inserted in the femoral vein in (9%), renal fellows (37%), medical residents with super-
bed-bound patients, including the critically ill, or in the vision (47%), radiologists (6%), and others (1%). Sterile
internal jugular vein in ambulatory patients. The latter technique included hand scrubbing, gown, glove, mask,
site is used in dialysis programs in which the resources and surgical drape. Skin was disinfected with 10% provi-
to immediately place cuffed, tunneled catheters are not odine (Professional Disposables Inc., Mississauga, On-
tario, Canada) and 70% isopropyl alcohol (Ingram and
Bell Medical, Don Mills, Ontario, Canada) or 2% chlor-Key words: central venous catheter, infection, dialysis, femoral cathe-
ter, jugular catheter, tunneled catheter. hexidine (Novopharm Ltd., Toronto, Ontario, Canada)
and alcohol. Exit sites were dressed with transparentReceived for publication March 28, 2000
dressings (Tegaderm; 3M, St. Paul, MN, USA).and in revised form June 9, 2000
Accepted for publication June 16, 2000 Bacteremia was defined as a positive blood culture
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Table 1. Likelihood of bacteremia from temporary hemodialysis exit site infection was 1.9% but increased to 13.4% by
catheters according to site of insertion and time of placement
the second day (Table 2).
Interval weeks Internal jugular Femoral The risk of bacteremia at an insertion site did not
0–1 1.7 3.1 increase with one or more guidewire exchanges for mal-
1–2 4.6 10.7 function [relative risk 0.9 per exchange (95% CI, 0.5 to
2–3 5.4 18.1
1.5)]. The risk of bacteremia and/or exit site infection3–4 10.3 29.1
during the catheterization period (includes all catheters
used for the patient) was not affected by age, male sex,
diabetes, immunosuppression, admission to the intensive
care unit, or chronic renal failure.confirmed as catheter related when the same organism
isolated from the blood was isolated from the catheter
tip or when the signs of bacteremia resolved shortly after DISCUSSION
removal of the catheter and no other source was found
In 1961, Shaldon, Chiandussi, and Higgs first intro-[2]. Exit site infection was defined as purulent drainage
duced temporary hemodialysis catheters, and these cath-from the exit site or when other signs of inflammation
eters continue to be the primary means of achievingoccurred (redness, pain, and swelling) in conjunction
acute hemodialysis access [5, 6]. The questions for clini-with a positive culture from the catheter tip [3].
cians are what is the risk of bacteremia and how longInfection-free survival was calculated using the life
should catheters remain in place before the risk is tootable method. Risk factors were analyzed using the multi-
high. This prospective study found a bacteremia rate ofvariable Cox proportional hazards model [4]. The entire
3.8 per 1000 catheter days, which is similar to othercatheterization period (all insertion sites) was modeled
prospective studies of temporary catheters that rangeto analyze patient factors, and individual insertion sites
from 3.9 to 9.7 bacteremias per 1000 catheter days [7–11].were modeled to analyze site of insertion and guidewire
exchange. The assumption of proportional hazards was However, the incidence of infection and risk of infection
verified by examined Schoenfeld residuals. Infection risk over time vary significantly according to site of insertion.
over time was evaluated by plotting the negative loga- Although this concept was reflected in the NFK-DOQI
rithm of the infection-free survival curve over time. guidelines on vascular access, which recommend removal
Analysis was performed with SAS system software (ver- of femoral catheters after five days of use and internal
sion 6.12; Cary, NC, USA). jugular catheters after three weeks of use, the authors
acknowledged this guideline was predominantly opinion
based. Our study shows that for bed-bound patients withRESULTS
femoral catheters, including the critically ill, the inci-
Catheters were placed in 218 patients. Seven patients dence of bacteremia rises rapidly after seven days of use.
transferred to another hemodialysis center with the cath-
The study was not powered to distinguish meaningfully
eter in place, so follow-up was complete on 211 patients
the different bacteremia rates between five and sevenover 6325 days. No other patients were excluded. Four
days of use. For ambulatory patients with internal jugularhundred seventeen individual catheters were inserted at
catheters, the incidence of bacteremia is acceptable until318 new insertion sites. There were 193 internal jugular,
three weeks of placement. These observations support91 femoral, and 34 subclavian insertions.
the current recommendations to remove catheters rou-Twenty-four catheter bacteremias occurred, resulting
tinely to prevent bacteremia [1]. We do acknowledge,in a rate of 3.8 per 1000 catheter days. The risk of bacter-
however, that a randomized comparison of routine re-emia varied significantly according to the duration of use
moval at a given time compared with leaving the catheterand site of insertion (Table 1). For the femoral site, the
in place has not been performed.bacteremia rate was 3.1% up to one week of placement,
In contrast to other investigators [9, 10], we foundbut increased to 10.7% by two weeks. The bacteremia
that patients were not exposed to a constant risk ofrate at the internal jugular site was 5.4% up to three
bacteremia over time, but rather the risk increased withweeks of use, but increased to 10.3% by the fourth week.
duration of use. The increase was greater for the femoralThe relative risk of bacteremia at the femoral site com-
catheters than internal jugular catheters. Because of thispared with the internal jugular site was 3.1 (95% CI,
difference in risk, the incidence of bacteremia was greater1.1 to 8.5). The risk of bacteremia increased weekly for
at the femoral site during each week of use and thefemoral catheters but did not increase until the third
difference between the sites increased as time passed.week for internal jugular catheters (Fig. 1).
An interesting relationship between exit infection andFifty-eight exit site infections occurred. Eleven of 24
bacteremia was also observed. First, exit site infection(46%) bacteremias were preceded by an exit site infec-
tion. The likelihood of bacteremia within one day of the is not a prerequisite for bacteremia. Approximately half
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Fig. 1. Hazard of bacteremia according to site
of insertion and duration of placement. This
plot of the negative logarithm of infection free
curve versus time provides an estimate of the
hazard (risk) of bacteremia over weekly time
intervals. The slope of the line estimates the
hazard. At one week, the hazard (risk) of in-
fection at the femoral site increases but re-
mains relatively flat for the internal jugular
site. At three weeks, the hazard increases at
both the femoral (solid line) and internal jugu-
lar (dashed line) sites.
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